The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Korenberg Matthew E since 2017.
This trader's CIK number is 1649903.
At the time of last reporting, Korenberg Matthew E was the President & COO of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | LGND | 0 | $0 | 70,748 | $6,925,228 | 14,754 | $751,477 |
| 2019 | LGND | 500 | $43,091 | 0 | $0 | 0 | $0 |
| 2018 | LGND | 0 | $0 | 18,357 | $4,712,058 | 11,540 | $990,016 |
| 2017 | LGND | 0 | $0 | 6,559 | $935,510 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-20 | LGND | Option Ex | 4,982 | 49.99 | 249,050 |
| 2024-09-20 | LGND | Sale | 6,275 | 104.10 | 653,240 |
| 2024-09-23 | LGND | Option Ex | 9,772 | 51.41 | 502,427 |
| 2024-09-23 | LGND | Sale | 9,772 | 101.24 | 989,287 |
| 2024-08-22 | LGND | Sale | 1,157 | 105.54 | 122,109 |
| 2024-08-23 | LGND | Sale | 6,312 | 104.61 | 660,317 |
| 2024-08-26 | LGND | Sale | 11,389 | 105.67 | 1,203,464 |
| 2024-08-09 | LGND | Sale | 18,245 | 98.50 | 1,797,132 |
| 2024-05-14 | LGND | Sale | 14,158 | 85.38 | 1,208,852 |
| 2024-05-13 | LGND | Sale | 3,440 | 84.54 | 290,827 |
| 2019-09-03 | LGND | Buy | 500 | 86.18 | 43,091 |
| 2018-08-29 | LGND | Sale | 18,357 | 256.69 | 4,712,058 |
| 2018-08-29 | LGND | Option Ex | 11,540 | 85.79 | 990,016 |
| 2017-11-17 | LGND | Sale | 6,559 | 142.63 | 935,510 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Korenberg Matthew E (President & COO of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.